See the DrugPatentWatch profile for Jatenzo
The generic name for Jatenzo is testosterone undecanoate [1].
What is testosterone undecanoate used for?
Testosterone undecanoate, marketed as Jatenzo, is an orally administered androgen medication. It is prescribed for testosterone replacement therapy (TRT) in adult men who have been diagnosed with hypogonadism, a condition characterized by the body's inability to produce sufficient testosterone [1].
How does Jatenzo work?
Testosterone undecanoate is an ester of testosterone that is absorbed into the lymphatic system after oral administration, bypassing the liver's first-pass metabolism to a significant extent. This mechanism allows for more consistent testosterone levels compared to other oral testosterone formulations [2].
When did Jatenzo become available?
Jatenzo was approved by the U.S. Food and Drug Administration (FDA) in April 2019 [3].
What are the potential side effects of Jatenzo?
Common side effects associated with Jatenzo include an increase in blood pressure, pain in the extremities, belching, and a higher level of prostate-specific antigen (PSA) [1]. It is important to note that testosterone therapy can also cause other side effects, such as acne, sleep apnea, and increased red blood cell count [4].
Are there alternatives to Jatenzo for testosterone replacement?
Yes, there are several alternative methods for testosterone replacement therapy. These include injectable testosterone, topical testosterone gels or solutions, and transdermal testosterone patches [4]. Each method has its own administration frequency, potential side effects, and absorption profiles.
What is the patent situation for Jatenzo?
Information regarding specific patent details for Jatenzo is available through resources like DrugPatentWatch.com [5]. Patents are crucial for pharmaceutical companies as they grant exclusive rights to market a drug for a certain period, preventing generic competition.
Who manufactures Jatenzo?
Jatenzo is manufactured by Lipocine Inc. [3].